Navigation Links
Lower carbon dioxide emissions from coal-fueled power plants possible with technology development

A more economical technology for a 90 percent reduction of carbon dioxide emissions from coal-fueled power plants is being developed by a chemical engineer and his colleagues at The University of Texas at Austin as part of the TXU Carbon Management Program.

TXU Power, a subsidiary of TXU Corp., will donate $1.8 million to the university in support of Chemical Engineering Professor Gary Rochelle and his research. The donation will cover a six-year program to improve an existing process for capturing carbon dioxide so it uses at least 10 percent less energy.

“The work we’re doing at The University of Texas at Austin will provide the technical understanding for companies to use this technology in prototype and commercial scale plants,?said Rochelle.

“With the current mix of new power plants, by the year 2030,?he said, “about two-thirds of all carbon dioxide emissions will come from existing coal-fueled power plants, so it is critical that we demonstrate technology to address these releases.?

The funds from TXU Power will be matched by funds from a dozen or more other power companies and process suppliers who will participate in the TXU Carbon Management Program. With these funds, Rochelle, holder of the Carol and Henry Groppe Professorship in Chemical Engineering, will optimize the chemical and mechanical features of a carbon capture technology that uses a liquid amine chemical.

“We are thrilled to team with a prestigious university such as UT Austin,?said Richard Wistrand, senior vice president and chief fossil officer, TXU Power. “TXU has outlined a vision to lower carbon dioxide emission rates through development of new technologies, and Dr. Rochelle’s research will undoubtedly make great strides toward this development.?

Rochelle spent the past six years developing the technology with funding from the U.S. Department of Energy and the Texas Advanced Technology Program. Like its commercial counterparts, his p
'"/>

Source:University of Texas at Austin


Page: 1 2 3

Related biology news :

1. FDA: Highly Unlikely Green Tea Lowers Cancer Risk
2. Deep sea algae connect ancient climate, carbon dioxide and vegetation
3. Microbe has huge role in ocean life, carbon cycle
4. Marine bacterium suspected to play role in global carbon and nitrogen cycles
5. High carbon dioxide levels spur Southern pines to grow more needles
6. Field tested: Grasslands wont help buffer climate change as carbon dioxide levels rise
7. Modifications render carbon nanotubes nontoxic
8. Climate change will affect carbon sequestration in oceans, model shows
9. Storing carbon to combat global warming may cause other environmental problems, study suggests
10. Bugs expose underground carbon traffic system 10 times more important than fossil fuel burning
11. Of mice, men, trees and the global carbon cycle
Post Your Comments:
(Date:8/20/2008)...nta, Ga. August 20, 2008) Today, the U.S. Environ... of a $2 million grant to the University of Kentuc... nanoparticles affect their ability to enter the b...Results (STAR) grant ever awarded to the Universit...ever awarded by EPA STAR for nanotechnology resear...
(Date:8/20/2008)...AKERS are supposed to protect people from heart at... as well as biological security. , Earlier this y...al School demonstrated how a commercial radio tran...tions from a pacemaker ( New Scientist, 22 March,...tor and adjust the implanted device, but a malicio...
(Date:8/20/2008)...entre for Addiction and Mental Health (CAMH) is pr...on by the Canada Foundation for Innovation (CFI) i...ntervention, treatment and prevention of mental il...e. , This funding from the Large-Scale Institut...tal Fund will allow CAMH to leverage our scientifi...
(Date:8/20/2008)...COLUMBUS, Ohio -- Researchers here have found a wa...gen very efficiently. , A new catalyst makes hyd...kable temperature, and using inexpensive ingredien...olecular engineering at Ohio State University, sai...n others being developed around the world, because...
Breaking Biology News(10 mins):$2M grant awarded to University of Kentucky for research on nanoparticles and human health 2How to stop a new type of heart attack 2Large-scale investment catapults CAMH's mental illness and addiction research forward 2A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 1Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 2Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 3Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 4Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 1Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 2Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 1Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 2Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 4Tracleer 28R 29 Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 619 1Tracleer 28R 29 Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 619 2Tracleer 28R 29 Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 619 3
...stration (FDA) today announced a series of importa...steroidal anti-inflammatory class of drugs, includ...ription (over-the-counter (OTC)) non-selective NSA...ble on the Internet at http://www.fda.gov/cder/dru...otect and advance the health of the millions of Am...
...Polytechnique Fédérale de Lausanne (EPFL) in Switz...ce to silence a mutated gene that causes inherited...tantially delaying both the onset and the progress...results will be published in the April issue of Na...e publication March 13. , In addition to silencing...
...stitute researchers chiseling away at the problem ...nation of how the drugs, main cellular target in b...se medications. The findings are already leading t...neered to circumvent resistance, which is a major ...z, a Howard Hughes Medical Institute investigator ...
...first time mapped multiple complex biological inte...m, enhancing our understanding of how the networks...uence one another. New research published in the O...uch maps can also reveal cryptic interactions and ...t haven,t been observed experimentally. , A living...
Other Biology News:FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2Silence the gene, save the cell: RNA interference as promising therapy for ALS 2Silence the gene, save the cell: RNA interference as promising therapy for ALS 3Researchers make gains in understanding antibiotic resistance 2Researchers make gains in understanding antibiotic resistance 3Navigating an integrated yeast network 2
(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
...d by the Circuit Court of Wisconsin in Milwaukee ...d businesses that acquired Microsoft software ov...ibute nearly $224 million back to them as part of ...against the software giant. , ,The notices are the...awsuits about whether Microsoft violated Wisconsin...
...rs is Japan. In this column, I have covered differ...y and biotech markets (3/10/03, 8/18/03, 3/28/05).... Bio-Jan 2006 Conference in September after a th...rticipate in the 30th anniversary celebration of t...ad started in Chicago and culminated in a series o...
...n will decide whether to change the current long-s... be patentable, an invention must not be "obvious"... it was created by the inventor, and any change in...mpact the ability to procure and enforce patents. ...riefs to appreciate the importance of this case: ...
...ate that the Greater Madison area, while a key U.S...ched the "critical mass" of talent, innovation, an...nts and achieve a state of sustained growth. , ,Bu...convened Tuesday to welcome an emerging drug disco...hern suburb of Madison, a different message emerge...
Other Biology Technology:Microsoft to distribute $224M as part of settlement 2Japan on the rebound: Implications for Midwest 2Japan on the rebound: Implications for Midwest 3Japan on the rebound: Implications for Midwest 4Japan on the rebound: Implications for Midwest 5Japan on the rebound: Implications for Midwest 6Japan on the rebound: Implications for Midwest 7Japan on the rebound: Implications for Midwest 8Japan on the rebound: Implications for Midwest 9Inventions could fall prey to Monday morning quarterbacking 2Inventions could fall prey to Monday morning quarterbacking 3Inventions could fall prey to Monday morning quarterbacking 4Caden Biosciences may signal critical mass 2
Mouse monoclonal antibody raised against a full length recombinant SLC25A11. NCBI Entrez Gene ID = SLC25A11
Mouse monoclonal antibody raised against a partial recombinant TOPORS. Immunogen: TOPORS (NP_005793, 98 a.a. ~ 206 a.a) partial recombinant protein with GST tag. Accession Number: NM_005802
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5
...al recombinant NFKBIB. Immunogen: NFKBIB (AAH1...in with GST tag. Protein Sequence: EDGDTALHLAV...GAGLCVAERRGHTALHLACRVGAHACARA Accession: BC015...: 604495, GeneID: 4793 Lot Number: MM9511...
Biology Products: